S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Tandem Diabetes CareIntegra LifeSciencesInspire Medical SystemsNevroHaemonetics
SymbolNASDAQ:TNDMNASDAQ:IARTNYSE:INSPNYSE:NVRONYSE:HAE
Price Information
Current Price$95.99$68.34$232.79$165.18$126.50
52 Week RangeBuyHoldBuyBuyBuy
MarketRank™
Overall Score1.41.41.41.21.6
Analysis Score2.31.22.42.42.5
Community Score2.52.22.43.02.2
Dividend Score0.00.00.00.00.0
Ownership Score1.71.71.70.01.7
Earnings & Valuation Score0.61.90.60.61.9
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$118.62$64.73$168.55$181.38$144.80
% Upside from Price Target23.57% upside-5.29% downside-27.60% downside9.81% upside14.47% upside
Trade Information
Market Cap$5.85 billion$5.77 billion$6.27 billion$5.69 billion$6.43 billion
Beta0.311.261.711.020.56
Average Volume731,632388,419235,333454,449374,646
Sales & Book Value
Annual Revenue$362.30 million$1.52 billion$82.05 million$390.26 million$988.48 million
Price / Sales16.143.8076.4214.576.50
CashflowN/A$4.27 per shareN/AN/A$5.60 per share
Price / CashN/A16.00N/AN/A22.59
Book Value$3.30 per share$16.50 per share$5.81 per share$6.98 per share$11.67 per share
Price / Book29.094.1440.0723.6610.84
Profitability
Net Income$-24,750,000.00$50.20 million$-33,240,000.00$-103,690,000.00$76.53 million
EPS($0.22)$2.74($1.40)($3.37)$3.31
Trailing P/E RatioN/A102.00N/AN/A61.11
Forward P/E RatioN/A23.57N/AN/A36.04
P/E GrowthN/A1.97N/AN/A5.17
Net Margins-11.10%4.10%-61.07%-24.46%11.76%
Return on Equity (ROE)-10.98%14.26%-32.23%-30.25%22.85%
Return on Assets (ROA)-5.59%5.77%-26.42%-14.57%10.40%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.61%1.08%0.11%0.37%0.44%
Current Ratio5.61%4.52%14.67%3.10%2.25%
Quick Ratio4.94%3.31%14.18%2.75%1.34%
Ownership Information
Institutional Ownership Percentage88.60%85.71%96.30%N/A96.22%
Insider Ownership Percentage6.00%4.30%6.60%7.60%1.63%
Miscellaneous
Employees1,0434,0002398533,004
Shares Outstanding60.91 million84.37 million26.94 million34.43 million50.82 million
Next Earnings Date4/29/2021 (Estimated)5/6/2021 (Estimated)5/4/2021 (Estimated)5/4/2021 (Estimated)5/4/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.